89Zr˗DFO˗REGN3504
R3504-ONC-1701
Phase 1 small_molecule terminated
Quick answer
89Zr˗DFO˗REGN3504 for Advanced PD-L1 Positive Malignancies is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Advanced PD-L1 Positive Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated